Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-002142
Filing Date
2014-02-14
Accepted
2014-02-14 09:03:26
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ombp20131231_10q.htm 10-Q 586833
2 EXHIBIT 31.1 ex31-1.htm EX-31 10855
3 EXHIBIT 31.2 ex31-2.htm EX-31 10685
4 EXHIBIT 32.1 ex32-1.htm EX-32 8246
  Complete submission text file 0001437749-14-002142.txt   2887335

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS ombp-20131231.xml EX-101.INS 276255
6 EXHIBIT 101.SCH ombp-20131231.xsd EX-101.SCH 31689
7 EXHIBIT 101.CAL ombp-20131231_cal.xml EX-101.CAL 10667
8 EXHIBIT 101.DEF ombp-20131231_def.xml EX-101.DEF 166478
9 EXHIBIT 101.LAB ombp-20131231_lab.xml EX-101.LAB 241708
10 EXHIBIT 101.PRE ombp-20131231_pre.xml EX-101.PRE 169209
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-52530 | Film No.: 14610823
SIC: 2836 Biological Products, (No Diagnostic Substances)